Please login to the form below
respiratory
This page shows the latest respiratory news and features for those working in and with pharma, biotech and healthcare.
Voice biomarker device could diagnose depression, heart disease
Sonde says its main focus is on depression, as well as a number of other mental health, respiratory and cardiovascular conditions where it believes remote, passive monitoring could help identify health ... It says it will now expand its research into
Latest news
-
Dovato approval key for Glaxo in HIV treatment
Christopher Pace, senior director of Infectious Diseases and Respiratory at data and analytics company GlobalData, predicts the new entrant will be a blockbuster.
-
Success for AZ, setback for Sanofi in type 1 diabetes
The improved glucose control was however accompanied with both drugs by an increased risk of diabetic ketoacidosis (DKA), a side effect that in severe cases can lead to kidney damage, respiratory
-
Is Orkambi deal close? Vertex meets again today with NHS England
Orkambi’s clinical trials show the drug can improve lung function and respiratory symptoms in people with the life-shortening condition, and could be appropriate for around 50% of sufferers, many
-
AZ says dropping MedImmune will help ‘streamline’ its R&D
biopharma covering cardiovascular, respiratory, and renal/metabolism projects – as the division straddled the two.
-
Novartis first to benefit from NICE advice on ‘patient preference’
The advice was provided to Novartis, and looked at a patient preference study for people with respiratory condition chronic obstructive pulmonary disease (COPD).
More from news
Approximately 26 fully matching, plus 511 partially matching documents found.
Latest Intelligence
-
Cutting through the noise: CRISPR
CRISPR libraries aren’t exclusively reserved for oncology, however. AstraZeneca has confirmed that it is applying the tech across other therapy areas, including cardiovascular, renal, metabolism and respiratory, with the continued
-
New models of NHS care – new models of pharma response?
The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease.
-
Deal Watch October 2018
Next the respiratory portfolio of GSK may be on the block after a widely reported comment by Alex Hoos, the head of oncology at GSK. ... The suggestion was that the strategic focus of GSK will be directed towards growth areas and that the respiratory
-
Lonely planet: why there is dwindling value in pharma travelling alone
An example is the real-world observational study GSK conducted for its respiratory treatment Relvar prior to regulatory approval.
-
China: AstraZeneca’s new engine for growth and innovation
He says the company is “very confident” of sustaining growth in China, and says its broad portfolio of medicines across oncology, respiratory and cardiovascular, metabolic and renal will help it achieve ... world. The company has what it calls a
More from intelligence
Approximately 0 fully matching, plus 70 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;
-
Alexion appoints new senior VP for EMEAC region
Her expertise lies in a range of therapeutic areas such as cardiovascular, diabetes, respiratory, ophthalmology and oncology.
-
Philips promotes Simon McGuire to health systems lead
He was previously GM at Philips Respironics Respiratory Drug Delivery. Technology company Philips has appointed Simon McGuire as its health systems lead for the UK and Ireland, reporting directly to chief ... McGuire was previously Philips' general
-
Makara Health appoints new associate director Helena Wright
She has previously held roles with GSK - where she worked on vaccines, respiratory and corporate communications - and Alliance Healthcare.
-
Teva's Mark Salyer joins Amarin
He joins the Irish biopharma company from Teva, where he served as general manager of its US respiratory division, and prior to that he held senior roles at GlaxSmithKline and Altana.
More from appointments
Approximately 0 fully matching, plus 46 partially matching documents found.
Latest from PMHub
-
What role for pharma in helping to deliver integrated care?
In common with all Sustainability and Transformation Partnerships (STPs), ICSs have certain areas that they must focus on under the Long Term Plan, such as diabetes, cancer and respiratory disease.
-
Putting disease prevention on a par with cure
with the use of anti-fungal paint would be more effective for managing and preventing illness in people with respiratory problems than drugs, and critically both approaches are funded from the
-
What does the new NHS plan mean for pharma?
with the use of anti-fungal paint, would be more effective for people with respiratory problems than drugs, and critically both approaches are funded from the same budget and strategic plan.
-
Random42 Scientific Communication Showreel 2015
As viewers, we can travel with red blood cells along arteries to explore cardiovascular concerns, or down the airways and into the lungs to illustrate respiratory issues.
-
Londonvelophobia (fear of cycling in London) – debunked
Pollution in London drastically needs addressing and for people who suffer from asthma, have heart conditions or respiratory issues, it’s still a serious concern, but getting more people cycling is
More from PMHub
Approximately 0 fully matching, plus 30 partially matching documents found.
Featured jobs
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
-
Director – Healthcare PR
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary and benefits
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Dovetail
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
